In September 2023 the FDA placed BPC-157 in Category 2 of its 503A interim bulk-substances policy, citing immunogenicity and peptide-characterization concerns, effectively excluding it from the 503A compounding bulk-substances list
Read "Best Time to Take GHK-Cu
Some people splitting into 2x/week report fewer GI sides, but it's not required
In several research studies in animals and cultured cells, this peptide has been shown to accelerate the healing of different kinds of wounds in tissues, including tendons, muscles, joints, ligaments and has also positive effects on inflammatory bowel disorders, gut problems, ulcers, skin or even nervous system and vascular grows
Used clinically in Russia, epithalon is heavily studied around the world for its demonstrated anti-aging, sleep-promoting, anti-cancer, and disease-fighting properties
The liver and mitochondria then lose their main defense against oxidative damage, allowing inflammation and toxin buildup to worsen